drugset / Press release
EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting
2026-04-22 · EvolveImmune United, Inc · original evolveimmune.com ↗
April 22, 2026 07:00 ET | Source: EvolveImmune Therapeutics
The release as fetched from its publisher. evolveimmune.com ↗